Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-02-23
1999-12-07
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 930DIG802, 4242781, A61K 3802, A61K 3808, C07K 706
Patent
active
059983760
ABSTRACT:
Substance P aerosols are effective in replenishing immune systems compromised by environmental toxicants. They are also useful for prophylaxis against and treatment of infections and neoplasms. They are useful for accelerating maturation of immune systems or maintaining immune function, as well. Chronic exposure to hydrocarbons is particularly damaging to the immune system, and thus this occupational hazard can be counteracted by treatment with substance P aerosols.
REFERENCES:
patent: 5314690 (1994-05-01), Patterson et al.
patent: 5410019 (1995-04-01), Coy et al.
Lotz et al., "B Cell Stimulating Factor 2/Interleukin 6 is a Costimulant for Human Thymocytes and T Lymphocytes", J. Exp. Med., 167:1253-1258 (1988).
Tammy Kincy-Cain et al., "Substance P-Induced IL-12 Production by Murine Macrophages", The American Association of Immunologists, 158(5):2334-2339 (1997).
Xiao-Ying Yu, "Protective effect of substance P on permeability of airway epithelial cells in culture", American Physiological Society 889-895, (1996).
Garman et al., "B-Cell-Stimulatory Factor 2 (.beta..sub.2 Interferon) Functions as a Second Ssignal for Interleukin 2 Production bvy Mature Murine T Cells", Proc. Natl. Acad. Sci. USA 84:7629-7633 (1987).
Pfaff et al., "Inhalation Exposure to JP-8 Jet Fuel Alters Pulmonary Function and Substance P Levels in Fischer 344 Rats", J. Appl. Toxicol 15(4):249-256 (1995).
Lotz et al., "Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes", Science 241:1218-1221 (1988).
Kincy-Cain et al., Increased Susceptibility of Mice to Salmonella Infection Following In Vivo Treatment with the Substance P Antagonist, Spantide II, The Journal of Immunology, 157:255-264, 1996.
Palermo et al., "Bronchospasm Induced by Inhalation of Substance P: Effect of Sodium Cromoglycate", Respiration 54:95-99 (1988).
Boichot et al., "Inhaled Substance P Induces Actgivation of Alveolar Macrophages and Increases Airway Responses in the Guinea-Pig", Neorpeptides 25(307-313 (1993).
Pfaff et al., "Neutral Endopeptidase (NEP) and its Role in Pathological Pulmonary Change with Inhalation Exposure to JP-8 Jet Fuel", Toxicology and Industrial Health 12(1):93-103 (1996).
Jurjus A, Walsh R, "Detection of substance P positive cells and nerve fibers in the rat thymus," The Faseb Journal, 11(3):A201, 1997.
Hays et al., "Changes in Lung Permeability Correlate with Lung Histology in a Chronic Exposure Model", Toxicology and Industrial Health 11(3):325-336 (1995).
Kudlacz E. J. Neuroimmunology, 50, 119-125, Jan. 1994.
Siemion I.Z. et al. Molecular Immunology, 27, 887-890, Sep. 1990.
Harris David T.
Witten Mark L.
Borin Michael
Tsang Cecilia J.
LandOfFree
Substance P treatment for immunostimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substance P treatment for immunostimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substance P treatment for immunostimulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-823808